Breast Cancer Risk Calculator - Gail-Style Five-Year and Lifetime
Use this breast cancer risk calculator to estimate 5-year and lifetime invasive breast cancer probability from age, family, and reproductive history.
Breast Cancer Risk Calculator
Results
What Is the Breast Cancer Risk Calculator?
A breast cancer risk calculator turns your age, race, reproductive history, family history, and any prior breast biopsies into an estimated probability of developing invasive breast cancer over the next five years and over a lifetime to age 90. This calculator is a BCRAT-inspired risk summary that applies the Gail 1989 relative risks to current SEER baseline invasive breast cancer rates. It is not the full official NCI BCRAT, which adds a competing-mortality adjustment. The official NCI BCRAT or Tyrer-Cuzick is the next step for a clinical-grade estimate.
- • Routine primary-care discussion: A woman in her 40s or 50s who wants to know how her history moves her number above or below the population average.
- • Pre-visit preparation: A patient with first-degree relatives with breast cancer who wants a structured summary for a clinic visit.
- • After a benign biopsy: A patient whose recent biopsy showed atypical hyperplasia and wants to translate that finding into a number.
The Gail relative risks were developed by Mitchell H. Gail and first published in 1989. The SEER baseline rates reflect 2015 to 2017 invasive breast cancer incidence by age and race, as published by the National Cancer Institute.
Menarche and menstrual history are inputs the calculator shares with Period Calculator, which can help you place the menarche question in the broader context of your menstrual history.
How the Gail-Style Risk Summary Works
The calculator reads your age, race, and the five relative-risk inputs, multiplies the five Gail 1989 relative risks into a combined relative risk factor, and applies that factor to the SEER baseline invasive breast cancer rate. The same combined relative risk scales the SEER lifetime-to-age-90 baseline. This is a simplified application of the Gail framework, not the full BCRAT.
- Age: Current age in years, used to pick the SEER 5-year baseline rate.
- Race or ethnicity: Used to pick the SEER baseline 5-year and lifetime rates.
- Combined relative risk: Product of the five Gail 1989 relative risks: menarche, first live birth, first-degree relatives, prior biopsies, and atypical hyperplasia.
The numeric answer is a structured summary, not a diagnosis. A high combined relative risk usually reflects one dominant factor, and the result is most useful when that input is named in the conversation.
Worked example: 50-year-old white woman with average history
Age 50, White, menarche 12 to 13, first live birth 25 to 29, no first-degree relatives, no biopsies, no atypical hyperplasia.
Combined relative risk = 1.10. SEER 5-year baseline at age 50, White = 2.40 percent.
5-year risk 2.64 percent, lifetime risk 14.19 percent, average 2.40 percent, relative risk 1.10.
Close to the SEER average for the same age and race. Routine screening is reasonable, and the calculator result is a starting point for a conversation rather than a clinical recommendation.
According to Gail MH, Brinton LA, Byar DP, et al. JNCI 1989, the relative risks are 1.21 and 1.10 for menarche before 12 and 12 to 13, 0.84 to 1.23 across first-birth bands, 2.61 to 13.50 across first-degree relative counts, 1.27 to 1.65 for biopsies, and 1.82 for atypical hyperplasia.
The Gail model does not include body mass index, so BMI Calculator can sit alongside this result if you also want to know how your current weight sits relative to the population.
Key Concepts Behind the Gail Relative Risks
The five relative risks the calculator multiplies together each capture a different angle on breast cancer probability. Knowing them helps you choose the input that matches the clinical record.
Menarche and lifetime estrogen exposure
A first period before age 12 extends the window of ovarian estrogen exposure, a driver of breast cell proliferation. The Gail 1989 encoding captures this with a 1.21 relative risk before 12 and 1.10 at 12 to 13.
First live birth and breast tissue maturation
A first full-term pregnancy before age 20 forces breast lobules to mature into a more stable Type 4 state, which is protective. A first live birth at 30 or older does not give the same protection, encoded with a 1.23 relative risk.
Family history of breast cancer
First-degree relatives raise the relative risk sharply: 2.61 for one, 6.80 for two, 13.50 for three or more. Three or more can also signal a hereditary syndrome such as a BRCA1 or BRCA2 carrier, where a different model is appropriate.
Prior biopsies and atypical hyperplasia
A history of breast biopsies is encoded as 1.27 for one and 1.65 for two or more, regardless of the pathology result. Atypical hyperplasia multiplies the relative risk by 1.82.
The SEER baseline rate, not a user input, is the largest single driver of the absolute 5-year and lifetime results because it varies by age and by race.
According to the NCI Breast Cancer Risk Assessment Tool (BCRAT), the official tool estimates a woman's chance of developing invasive breast cancer over the next five years and up to age 90 using her medical and reproductive history and her first-degree family history. The full BCRAT adds a competing-mortality adjustment that this simplified calculator does not implement.
Alcohol is not part of the Gail model but is a well-established modifiable risk factor, so Alcohol Units Calculator gives a structured weekly alcohol count that you can bring to the same lifestyle conversation.
How to Use This Calculator
Treat the calculator as a structured summary for a conversation with your clinician. Record the values you chose so they can be challenged in the visit.
- 1 Enter your current age and race or ethnicity: Age is used to pick the SEER 5-year baseline rate. Race picks the SEER lifetime baseline and the 5-year rates for your age bracket.
- 2 Pick the menarche and first-birth bands: First period before 12 maps to 1.21, 12 to 13 to 1.10, 14 or older to 1.00. First live birth before 20 maps to 0.84, 20 to 24 to 0.93, 25 to 29 to 1.00, 30 or older to 1.23.
- 3 Count first-degree relatives and biopsies: Mother, sisters, and daughters count. Each prior biopsy adds 1.27 for one and 1.65 for two or more. Atypical hyperplasia multiplies the relative risk by 1.82.
- 4 Read the result panel and bring the inputs to a clinical visit: The result panel surfaces the 5-year risk, the lifetime risk, the average for the same age and race, the relative risk ratio, and a Gail-style band. Share the inputs and ask whether a clinical-grade BCRAT or Tyrer-Cuzick estimate is appropriate.
A 47-year-old Black or African American woman with a mother who had breast cancer at 52, a first period at 11, a first live birth at 32, and one prior biopsy. Her combined relative risk is 4.93, well above the SEER average. The next conversation should include earlier or more frequent screening and a hereditary cancer referral discussion.
If you are weighing the first-birth and family-history inputs against current fertility decisions, Fertility by Age Calculator gives an age-specific fertility context that pairs with this conversation.
Benefits of a Gail-Style Risk Summary
A Gail-style risk summary can be done on paper, but a calculator makes the result transparent, repeatable, and easier to compare to the published bands.
- • Structured summary before a screening visit: The 5-year and lifetime numbers are written down with the inputs that produced them.
- • Direct comparison to the population average: The result panel surfaces the SEER baseline for the same age and race alongside your own number.
- • Translates atypical hyperplasia into a number: Atypical hyperplasia on a prior biopsy is encoded as a 1.82 relative risk.
- • Maps to the published Gail and BCRAT bands: The band cues follow the Gail 1989 thresholds and the BCRAT clinical interpretation.
The Gail model was designed to make breast cancer probability easier to discuss. This calculator does not diagnose breast cancer or replace a clinical exam. A clinical-grade risk estimate from the official NCI BCRAT or Tyrer-Cuzick is the appropriate next step before any screening or prevention decision.
Central adiposity is a separate modifiable risk factor that the Gail model does not capture, so Waist-to-Hip Ratio Calculator is a useful follow-up if you want to know how your current waist-to-hip ratio sits relative to the population.
Factors That Affect the Result
Several clinical realities can move the result up or down, and a few important ones are not part of the Gail model or this summary at all.
Age at first period and first live birth
Earlier menarche and a first live birth at 30 or older both raise the relative risk. A first live birth before 20 is the only reproductive-history input that lowers it.
Family history and hereditary syndromes
Two or more first-degree relatives with breast cancer raise the relative risk sharply. Three or more first-degree relatives, male breast cancer, ovarian cancer, or a known BRCA1 or BRCA2 variant signal that the Gail model may underestimate risk and a hereditary cancer genetics referral is appropriate.
Body weight, alcohol, and hormone therapy
Body mass index, alcohol, and combined hormone therapy are well-established modifiable risk factors, but neither the Gail model nor this calculator includes them.
- • The Gail model was validated in the United States for women who identify as White, Black or African American, Hispanic, or Asian or Pacific Islander. The American Indian or Alaska Native group is partly based on White SEER rates.
- • The Gail model cannot accurately estimate risk for women carrying a BRCA1 or BRCA2 variant, for women with a previous history of breast cancer, or for women with lobular carcinoma in situ. Tyrer-Cuzick, BOADICEA, or a genetics referral is more appropriate.
The calculator intentionally stops at the risk band and the suggested next conversation. The clinical decision still belongs to the user and the clinician, and a high-band result here is a reason to request the official NCI BCRAT or a Tyrer-Cuzick estimate, not a stand-alone recommendation.
According to NCI, the average 5-year risk of invasive breast cancer is 0.49 percent at age 30, 1.55 percent at age 40, 2.40 percent at age 50, 3.54 percent at age 60, and 4.09 percent at age 70. The lifetime risk is 12.9 percent for women born in the United States today.
Because the Gail model does not include body composition, Body Fat Percentage Calculator fits the same visit if you also want to know how your current body fat percentage sits relative to the population.
Frequently Asked Questions
Q: Is this the official NCI BCRAT tool?
A: No. This is a transparent, BCRAT-inspired risk summary, not the official NCI Breast Cancer Risk Assessment Tool. It applies the published Gail 1989 relative risks to current SEER baseline invasive breast cancer rates in a simplified way. For a clinical-grade risk estimate that includes competing-mortality adjustment, use the official NCI BCRAT or Tyrer-Cuzick.
Q: How is the 5-year probability calculated step by step?
A: The calculator picks the SEER baseline 5-year invasive breast cancer rate for your age and race, picks the five published Gail 1989 relative risks for your menarche band, first live birth band, first-degree relative count, prior biopsy count, and atypical hyperplasia finding, multiplies the five relative risks into a combined relative risk factor, and multiplies the combined relative risk by the SEER baseline.
Q: What does a 5-year probability of 1.7 percent mean?
A: A 5-year number of about 1.67 percent or higher is the Gail-style threshold for the elevated band. It means the calculator places you above the average for the same age and race, and the suggested next conversation is a review of the inputs with your clinician.
Q: How does family history change the result?
A: First-degree relatives (mother, sisters, and daughters) with breast cancer each raise the combined relative risk. The Gail 1989 encoding gives 2.61 for one first-degree relative, 6.80 for two, and 13.50 for three or more.
Q: Does atypical hyperplasia raise the result?
A: Yes. Atypical hyperplasia is a benign pathology finding in the breast lobules or ducts that raises invasive cancer probability in either breast. The Gail 1989 encoding gives a 1.82 relative risk, which on its own can move the result into the elevated or high band.
Q: How accurate is the Gail model?
A: The Gail model was validated in the Costantino 1999 reanalysis and is the most widely used first-pass risk model in primary care. It works less well for women with a strong family history of breast or ovarian cancer, for BRCA1 or BRCA2 carriers, and for women with a prior history of breast cancer, in which case Tyrer-Cuzick, BOADICEA, or a hereditary cancer genetics referral is more appropriate.